Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.87 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.69 |
| ▸ | NAAA | Q02083 | 1/20 | 0.65 |
| ▸ | PAM | P19021 | 2/20 | 0.64 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.64 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.64 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21044701 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL542897 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL2396240 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| Decane SCHEMBL20893697 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL21044727 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL4301741 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL7750961 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL395831 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL8444191 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 | |
| SCHEMBL11359267 | 1.00 | DGKA (0.87) | DGKADNM1NAAAPAMPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066515-A1 | METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, METHOD FOR PRODUCING CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-02-27 | — | — | US | disclosed |
| US-12234312-B2 | Solid catalyst component for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-02-25 | — | — | US | disclosed |
| US-12173107-B2 | Solid catalyst component for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-12-24 | — | — | US | disclosed |
| CN-119161509-A | Solid catalyst component for olefin polymerization | 住友化学株式会社 | 2024-12-20 | — | — | CN | disclosed |
| CN-114057913-B | Solid catalyst component for olefin polymerization | 住友化学株式会社 | 2024-10-11 | — | — | CN | disclosed |
| WO-2024204526-A1 | COMPOSITION FOR ATTRACTING TERRESTRIAL MOLLUSKS | 国立大学法人信州大学 | 2024-10-03 | — | — | WO | disclosed |
| US-20240076423-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-03-07 | — | — | US | disclosed |
| CN-113105690-B | Heterophasic propylene polymer material and use thereof | 住友化学株式会社 | 2024-03-01 | — | — | CN | disclosed |
| US-11840595-B2 | Solid catalyst component for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-12-12 | — | — | US | disclosed |
| CN-116925939-A | Construction method and application of engineering bacteria for producing fatty acid ester | 北京化工大学 | 2023-10-24 | — | — | CN | disclosed |
| CN-104135997-A | ASCORBIC ACID DERIVATIVE COMPOSITION AND METHOD FOR PRODUCING SAME, ASCORBIC ACID DERIVATIVE SOLUTION, AND EXTERNAL PREPARATION FOR SKIN | SHOWA DENKO KK | 2014-11-05 | — | — | CN | disclosed |
| US-20130143306-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2013-06-06 | — | — | US | disclosed |
| US-8399227-B2 | Methods and compositions for the recombinant biosynthesis of fatty acids and esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2013-03-19 | — | — | US | disclosed |
| US-20120184758-A1 | Continuous Transesterification Method | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-07-19 | — | — | US | disclosed |
| CN-102471724-A | Continuous transesterification process | CLARIANT FINANCE BVI LTD | 2012-05-23 | — | — | CN | disclosed |
| US-20120009636-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2012-01-12 | — | — | US | disclosed |
| US-8048654-B2 | Methods and compositions for the recombinant biosynthesis of fatty acids and esters | JOULE UNLIMITED TECHNOLOGIES, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| US-20110111470-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | JOULE UNLIMITED, INC. (US) | 2011-05-12 | — | — | US | disclosed |
| WO-2010115578-A2 | NOVEL COMPOUNDS SUITED AS DIESEL SUPPLEMENTS AND DIESEL SUBSTITUTES AND ROUTES FOR THEIR SYNTHESIS | ETH ZURICH (CH) | 2010-10-14 | — | — | WO | disclosed |
| US-20100210745-A1 | Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes | REACTIVE SURFACES, LTD. (US) | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110111470-A1 | Methods and Compositions for the Recombinant Biosynthesis of Fatty Acids and Esters | FASN, FADS2, FADS1 | DGKA 215/4885DNM1 3867/4885NAAA 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.